发明名称 |
Azaftig, a proteoglycan for monitoring cachexia and for control of obesity |
摘要 |
A proteoglycan ("azaftig") with a molecular weight of approximately 24,000 Dalton has been isolated and partially characterized from the urine of cachectic cancer and non-cancer patients. Azaftig has been shown to bind to receptors on fat cell membranes, and to cause lipolysis. Azaftig does not bind to muscle cell membranes, or cause proteolysis in muscle tissue. Azaftig detection in urine or other body fluids will allow early identification of patients in which weight loss may become a problem. Azaftig may also aid fat loss in humans in which obesity is a threat to health. |
申请公布号 |
AU4725099(A) |
申请公布日期 |
2000.01.17 |
申请号 |
AU19990047250 |
申请日期 |
1999.06.28 |
申请人 |
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULT |
发明人 |
CHANDAN PRASAD;JULIO E. FIGUEROA II;PARAKAT VIJAYAGOPAL |
分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|